Cargando…

Experimental Activation of Endocannabinoid System Reveals Antilipotoxic Effects on Cardiac Myocytes

Hypertension coincides with myocardial alternations in lipid (including sphingolipids) and glucose metabolism. The latest data indicate that accumulation of metabolically active lipids, especially ceramide (CER) and diacylglycerol (DAG) significantly influences intracellular signaling pathways along...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harasim-Symbor, Ewa, Polak-Iwaniuk, Agnieszka, Konstantynowicz-Nowicka, Karolina, Bielawiec, Patrycja, Malinowska, Barbara, Kasacka, Irena, Chabowski, Adrian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221735/ https://www.ncbi.nlm.nih.gov/pubmed/32326330 http://dx.doi.org/10.3390/molecules25081932

Ejemplares similares

High-Fat Feeding in Time-Dependent Manner Affects Metabolic Routes Leading to Nervonic Acid Synthesis in NAFLD
por: Konstantynowicz-Nowicka, Karolina, et al.
Publicado: (2019)

Chronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity
por: Bielawiec, Patrycja, et al.
Publicado: (2020)

Arachidonic Acid as an Early Indicator of Inflammation during Non-Alcoholic Fatty Liver Disease Development
por: Sztolsztener, Klaudia, et al.
Publicado: (2020)

Attenuation of Oxidative Stress and Inflammatory Response by Chronic Cannabidiol Administration Is Associated with Improved n-6/n-3 PUFA Ratio in the White and Red Skeletal Muscle in a Rat Model of High-Fat Diet-Induced Obesity
por: Bielawiec, Patrycja, et al.
Publicado: (2021)

Cannabidiol Downregulates Myocardial de Novo Ceramide Synthesis Pathway in a Rat Model of High-Fat Diet-Induced Obesity
por: Charytoniuk, Tomasz, et al.
Publicado: (2022)

Cannabidiol improves muscular lipid profile by affecting the expression of fatty acid transporters and inhibiting de novo lipogenesis
por: Bielawiec, Patrycja, et al.
Publicado: (2023)

Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol
por: Bielawiec, Patrycja, et al.
Publicado: (2020)

How Hypertension Affects Heart Metabolism
por: Polak-Iwaniuk, Agnieszka, et al.
Publicado: (2019)

Time-Dependent Changes in Hepatic Sphingolipid Accumulation and PI3K/Akt/mTOR Signaling Pathway in a Rat Model of NAFLD
por: Sztolsztener, Klaudia, et al.
Publicado: (2021)

Distinct Effects of Cannabidiol on Sphingolipid Metabolism in Subcutaneous and Visceral Adipose Tissues Derived from High-Fat-Diet-Fed Male Wistar Rats
por: Berk, Klaudia, et al.
Publicado: (2022)

Beneficial Changes in Rat Vascular Endocannabinoid System in Primary Hypertension and under Treatment with Chronic Inhibition of Fatty Acid Amide Hydrolase by URB597
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2021)

Vasoprotective Endothelial Effects of Chronic Cannabidiol Treatment and Its Influence on the Endocannabinoid System in Rats with Primary and Secondary Hypertension
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2021)

How Does CBG Administration Affect Sphingolipid Deposition in the Liver of Insulin-Resistant Rats?
por: Bzdęga, Wiktor, et al.
Publicado: (2023)

Vitamin K2 as a New Modulator of the Ceramide De Novo Synthesis Pathway
por: Kołakowski, Adrian, et al.
Publicado: (2021)

The Influence of Coumestrol on Sphingolipid Signaling Pathway and Insulin Resistance Development in Primary Rat Hepatocytes
por: Zywno, Hubert, et al.
Publicado: (2021)

New Evidence for the Role of Ceramide in the Development of Hepatic Insulin Resistance
por: Konstantynowicz-Nowicka, Karolina, et al.
Publicado: (2015)

Can Physical Activity Support the Endocannabinoid System in the Preventive and Therapeutic Approach to Neurological Disorders?
por: Charytoniuk, Tomasz, et al.
Publicado: (2020)

How do phytocannabinoids affect cardiovascular health? An update on the most common cardiovascular diseases
por: Dziemitko, Sylwia, et al.
Publicado: (2023)

The Endocannabinoid System and Physical Activity—A Robust Duo in the Novel Therapeutic Approach against Metabolic Disorders
por: Charytoniuk, Tomasz, et al.
Publicado: (2022)

Chronic Cannabidiol Administration Fails to Diminish Blood Pressure in Rats with Primary and Secondary Hypertension Despite Its Effects on Cardiac and Plasma Endocannabinoid System, Oxidative Stress and Lipid Metabolism
por: Remiszewski, Patryk, et al.
Publicado: (2020)

Serum sphingolipid level in psoriatic patients with obesity
por: Kozłowska, Dorota, et al.
Publicado: (2019)

Lipid profile disturbances may predispose psoriatic patients to liver dysfunction
por: Kozłowska, Dorota, et al.
Publicado: (2021)

Serum fatty acid binding protein 5 (FABP5) as a potential biomarker of inflammation in psoriasis
por: Kozłowska, Dorota, et al.
Publicado: (2021)

Concentration-Dependent Attenuation of Pro-Fibrotic Responses after Cannabigerol Exposure in Primary Rat Hepatocytes Cultured in Palmitate and Fructose Media
por: Sztolsztener, Klaudia, et al.
Publicado: (2023)

Serum fatty acid profile in psoriasis and its comorbidity
por: Myśliwiec, Hanna, et al.
Publicado: (2017)

Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease
por: Wasilewska, Natalia, et al.
Publicado: (2018)

Abnormal serum fatty acid profile in psoriatic arthritis
por: Mysliwiec, Hanna, et al.
Publicado: (2019)

Lack of pronounced changes in the expression of fatty acid handling proteins in adipose tissue and plasma of morbidly obese humans
por: Grzegorczyk, Ewa Anna, et al.
Publicado: (2018)

Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients
por: Myśliwiec, Hanna, et al.
Publicado: (2016)

Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment
por: Berk, Klaudia, et al.
Publicado: (2021)

Antilipotoxicity Activity of Osmanthus fragrans and Chrysanthemum morifolium Flower Extracts in Hepatocytes and Renal Glomerular Mesangial Cells
por: Tsai, Po-Jung, et al.
Publicado: (2017)

Does the enterolactone (ENL) affect fatty acid transporters and lipid metabolism in liver?
por: Drygalski, Krzysztof, et al.
Publicado: (2017)

Biomarkers of Glucose Metabolism Alterations and the Onset of Metabolic Syndrome in Survivors of Childhood Acute Lymphoblastic Leukemia
por: Konończuk, Katarzyna, et al.
Publicado: (2022)

Molecular Advances in MAFLD—A Link between Sphingolipids and Extracellular Matrix in Development and Progression to Fibrosis
por: Kołakowski, Adrian, et al.
Publicado: (2022)

Asymptomatic Survivors of Childhood Acute Lymphoblastic Leukemia Demonstrate a Biological Profile of Inflamm-Aging Early in Life
por: Latoch, Eryk, et al.
Publicado: (2022)

Delta-6 desaturase (Fads2) deficiency alters triacylglycerol/fatty acid cycling in murine white adipose tissue
por: Wang, Chenxuan, et al.
Publicado: (2023)

Wnt/β-catenin signaling in the adrenal glands of rats in various types of experimental hypertension
por: Kasacka, Irena, et al.
Publicado: (2022)

Multidirectional Effects of Tormentil Extract on Hemostasis in Experimental Diabetes
por: Marcinczyk, Natalia, et al.
Publicado: (2021)

Methodology for Precision Land Use Mapping towards Sustainable Urbanized Land Development
por: Szarek-Iwaniuk, Patrycja, et al.
Publicado: (2022)

Immunohistochemical Identification and Assessment of the Location of Immunoproteasome Subunits LMP2 and LMP7 in Acquired Cholesteatoma
por: Rutkowska, Justyna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p446k3dnl6hcfrpipetdgbs22p